Our experts are industry leaders with experience in pre and post-Life Cycle Management and Loss of Exclusivity (LOE) strategies of innovator (branded) pharmaceutical products, as well as launching PIV and 505B-2 products.
Key Areas of practice include:
- Analysis of Pharmaceutical Antitrust Litigation
- Supply Chain
- Distribution
- Contract Manufacturing
- Packaging
- Pricing
- Marketing Strategy
- Authorized Generics
- 505-b-2
- Sarbanes-Oxley Act compliance for the Managed Care
- Government and Guaranteed Pricing Contracts
- Market access compliance
- Market access contracts with Pharmaceutical Benefit Managers (PBMs) and Health Management Organizations (HMOs)
- Clinical Studies
- ANDAs
- Bioequivalency studies
- Patent Valuation
- Product and Technology Licensing
